15
Views
4
CrossRef citations to date
0
Altmetric
Special Report

Antioxidant enzyme deficiencies and vascular disease

Pages 15-18 | Published online: 10 Jan 2014

References

  • Loscalzo J, Leopold JA. Oxidative enzymopathies. Arterioscler. Thromb. Vasc. Biol.25, 1332–1340 (2005).
  • Cappadoro M, Giribaldi G, O’Brien E et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood92, 2527–2534 (1998).
  • Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J.15, 1771–1773 (2001).
  • Leopold JA, Zhang YY, Scribner AW, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler. Thromb. Vasc. Biol.23, 411–417 (2003).
  • Leopold JA, Walker J, Scribner AW et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem.278, 32100–32106 (2003).
  • Forgione MA, Loscalzo J, Holbrook M et al. Glucose-6-phosphate dehydrogenase deficiency, lipid peroxidation, and vascular oxidant stress in African–Americans. Circulation104, II-295 (2001).
  • Vasan RS, Evans JC, Larson MG et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N. Engl. J. Med.351, 8–10 (2004).
  • Leopold JA, Dam A, Maron BA et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med.13, 89–197 (2007).
  • Maron BA, Zhang YY, Handy DE et al. Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J. Biol. Chem.184, 7665–7672 (2009).
  • Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation96, 25–28 (1997).
  • Zhang Z, Apse K, Pang J, Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem.275, 40042–40047 (2000).
  • Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am. J. Physiol. Renal Physiol.289, F1040–F1047 (2005).
  • Eberhardt RT, Forgione MA, Cap A et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest.106, 483–491 (2000).
  • Handy DE, Zhang Y, Loscalzo J. Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J. Biol. Chem.280, 15518–15525 (2005).
  • Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl Acad. Sci. USA98, 12503–12508 (2001).
  • Blankenberg S, Rupprecht HJ, Bickel C et al.; for the AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N. Engl. J. Med.349, 1605–1613 (2003).
  • Handy DE, Hang G, Scolaro J et al. Aminoglycosides decrease glutathione peroxidase-1 activity by interfering with selenocysteine incorporation. J. Clin. Invest.281, 3382–3388 (2006).
  • Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J. Clin. Invest.97, 979–987 (1996).
  • Kenet G, Freedman J, Shenkman B et al. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler. Thromb. Vasc. Biol.19, 2017–2023 (1999).
  • Voetsch B, Jin RC, Bierl C et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke38, 41–49 (2007).
  • Voetsch B, Jin RC, Bierl C et al. Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke39, 303–307 (2008).
  • Jin RC, Mahoney CE, Coleman L et al. Deficiency of glutathione peroxidase-3 promotes platelet activation in vivo. Circulation118, S552 (2008).
  • Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res.88, 756–762 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.